biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 biotech firms expanding glp-1 use

However, more research is needed to completely comprehend the connection between dietary factors and FTO gene polymorphisms in determining the risk of SA

Cost varies, but many insurers require prior authorization

Bioactivity, health benefits, and related molecular mechanisms of curcumin: Current progress, challenges, and perspectives

If you choose to supplement with vitamin C, start with modest doses of 500mg to 1000mg daily and monitor for any worsening of GI symptoms

I think many beverage companies in particular feel like theyre already well-positioned [to accommodate potential changes in consumer habits from more widespread use of GLP-1 drugs] with their portfolios of low- and no-sugar options

Note: California (Medi-Cal) restricted GLP-1 coverage for weight loss effective January 1, 2026